C. Lu
Impact in
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
-
- Drug Transport and Resistance Mechanisms
- HER2/EGFR in Cancer Research
Papers in ⓘ
- Oncology 3
- Cancer Treatment and Pharmacology 2
- Colorectal Cancer Treatments and Studies 2
- Vascular Tumors and Angiosarcomas 1
-
- Pharmacogenetics and Drug Metabolism 3
- Co-authors
- Y Sakai (1 shared paper)Albert P. Li (1 shared paper)Isaiah W. Dimery (3 shared papers)John V. Heymach (3 shared papers)Roy S. Herbst (3 shared papers)P. Fidias (3 shared papers)Ajit Suri (1 shared paper)Karthik Venkatakrishnan (1 shared paper)
- Journals
- Journal of Clinical Oncology (4 papers)Clinical Pharmacology & Therapeutics (1 paper)International Journal of Pharmaceutics X (1 paper)Applied Organometallic Chemistry (1 paper)IEEE Transactions on Instrumentation and Measurement (1 paper)
- Partner nations
- United StatesChinaHong Kong
In The Last Decade
C. Lu
9 papers receiving 274 citations
Hit Papers
Peers
Comparison fields: 5 of 78
- Pharmacology 114
- Oncology 101
- Hepatology 25
- Pharmaceutical Science 13
- Chemical Health and Safety 1
Countries citing papers authored by C. Lu
This map shows the geographic impact of C. Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Lu more than expected).
Fields of papers citing papers by C. Lu
This network shows the impact of papers produced by C. Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Lu. The network helps show where C. Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside C. Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Effects of organic solvents on the activities of cytochrome P450 isoforms, UDP-dependent glucuronyl transferase, and phenol sulfotransferase in human hepatocytes. | 2001 | 164 |
| 2 | 2005 | 36 | |
| 3 | Ultra-sensitive pH responsive hydrogels with injectable and self-healing performance for controlled drug delivery Hit paper breakdown → | 2025 | 24 |
| 4 | 2015 | 21 | |
| 5 | 2004 | 17 | |
| 6 | 2005 | 7 | |
| 7 | 2024 | 6 | |
| 8 | 2004 | 5 | |
| 9 | 2024 | 4 | |
| 10 | 1999 | 0 |
About C. Lu
C. Lu is a scholar working on Oncology, Pharmacology, Pulmonary and Respiratory Medicine, Pharmaceutical Science and Hepatology, having authored 10 papers that have together received 284 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers), Cancer Treatment and Pharmacology (2 papers), Colorectal Cancer Treatments and Studies (2 papers), Gas Sensing Nanomaterials and Sensors (1 paper), Advanced Fiber Optic Sensors (1 paper), Vascular Tumors and Angiosarcomas (1 paper) and Chemical Reactions and Isotopes (1 paper). The work is most often cited by research in Pharmacology (114 citations), Oncology (101 citations), Hepatology (25 citations), Pharmaceutical Science (13 citations) and Chemical Health and Safety (1 citation). C. Lu has collaborated with scholars based in United States, China and Hong Kong. Frequent co-authors include Y Sakai, Albert P. Li, Isaiah W. Dimery, John V. Heymach, Roy S. Herbst, P. Fidias, Ajit Suri, Karthik Venkatakrishnan, Sunny Chapel and Edit Csada. Their work appears in journals such as Journal of Clinical Oncology, Clinical Pharmacology & Therapeutics, International Journal of Pharmaceutics X, Applied Organometallic Chemistry and IEEE Transactions on Instrumentation and Measurement.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.